Cannabis Science Inc. Signs Multi-Company Acquisition & Licensing Deals that will Boost Revenues, its Pharmaceutical Operations and Management Team While Bringing Cannabis Science Brand Products for National Distribution

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that it has signed a major multi-company acquisition agreement that will boost revenues, strengthen pharmaceutical operations and our management team.